Key facts
- CVC Capital Partners is exploring the sale of its personal care platform, Arthea.
- The potential sale could value Arthea at approximately $2 billion.
- Investment banks Moelis and William Blair are advising on the transaction.
- Arthea's brands include Dr. Teal's, Cantu, Bodycology, Body Fantasies, and BOD Man.
- CVC acquired the company, then known as PDC Brands, for $1.43 billion in 2017.
Private equity firm CVC Capital Partners is exploring the sale of Arthea, the owner of popular personal care brands such as Dr. Teal's and Cantu. The potential transaction could value the company at around $2 billion. CVC has enlisted investment banks Moelis and William Blair to manage the process, though discussions are reportedly in their early stages.
Arthea, previously known as PDC Brands, rebranded to Arthea in August, drawing from the words 'art' and 'healing.' The company also launched a new body care brand for tweens called Sunryz. CVC acquired the company for $1.43 billion in 2017 from Yellow Wood Partners.
Founded in 1981 and based in White Plains, New York, Arthea's portfolio also includes Bodycology, fragrance makers Body Fantasies and BOD Man, and textured hair care brand Cantu. Its products are distributed in over 80 countries.
This potential sale comes amid a busy period for the personal care industry, with notable transactions including L'Oreal's $4.7 billion acquisition of Kering's beauty unit and Henkel's $1.4 billion purchase of Olaplex. Wella Company, owner of OPI nail polish, recently filed for a U.S. IPO, signaling continued investor interest in consumer brands.